Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wouter A P Breeman

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Bioconjugate Chemistry|July 5, 2012
Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purityDirk Mueller, Ingo Klette, Richard P Baum, et al.
Nuclear Medicine and Biology|July 18, 2018
Semi-automated system for concentrating <sup>68</sup>Ga-eluate to obtain high molar and volume concentration of <sup>68</sup>Ga-Radiopharmaca for preclinical applicationsErik de Blois, Rory M S de Zanger, Elisabeth Oehlke, et al.
Current Radiopharmaceuticals|March 16, 2015
Accurate assessment of whole-body retention for PRRT with (177)Lu using paired measurements with external detectorsBoxue Liu, Erik de Blois, Wouter A P Breeman, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 15, 2010
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptidesErik de Blois, Ho Sze Chan, Clive Naidoo, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticalsErik de Blois, Rory M S de Zanger, Ho Sze Chan, et al.
Current Radiopharmaceuticals|March 16, 2015
Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRTWouter A P Breeman, Ho Sze Chan, Rory M S de Zanger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2005
Radiolabelling DOTA-peptides with 68GaWouter A P Breeman, Marion de Jong, Erik de Blois, et al.
Seminars in Nuclear Medicine|June 1, 2011
(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectivesWouter A P Breeman, Erik de Blois, Ho Sze Chan, et al.
Nature Protocols|May 13, 2016
Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution methodDirk Mueller, Wouter A P Breeman, Ingo Klette, et al.
Nuclear Medicine and Biology|July 13, 2004
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+Wouter A P Breeman, Maarten Th M De Jong, Erik De Blois, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Bioconjugate Chemistry|July 5, 2012
Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purityDirk Mueller, Ingo Klette, Richard P Baum, et al.
Nuclear Medicine and Biology|July 18, 2018
Semi-automated system for concentrating <sup>68</sup>Ga-eluate to obtain high molar and volume concentration of <sup>68</sup>Ga-Radiopharmaca for preclinical applicationsErik de Blois, Rory M S de Zanger, Elisabeth Oehlke, et al.
Current Radiopharmaceuticals|March 16, 2015
Accurate assessment of whole-body retention for PRRT with (177)Lu using paired measurements with external detectorsBoxue Liu, Erik de Blois, Wouter A P Breeman, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|December 15, 2010
Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptidesErik de Blois, Ho Sze Chan, Clive Naidoo, et al.
EJNMMI Radiopharmacy and Chemistry|October 30, 2019
Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticalsErik de Blois, Rory M S de Zanger, Ho Sze Chan, et al.
Current Radiopharmaceuticals|March 16, 2015
Overview of Development and Formulation of ¹⁷⁷Lu-DOTA-TATE for PRRTWouter A P Breeman, Ho Sze Chan, Rory M S de Zanger, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 19, 2005
Radiolabelling DOTA-peptides with 68GaWouter A P Breeman, Marion de Jong, Erik de Blois, et al.
Seminars in Nuclear Medicine|June 1, 2011
(68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectivesWouter A P Breeman, Erik de Blois, Ho Sze Chan, et al.
Nature Protocols|May 13, 2016
Radiolabeling of DOTA-like conjugated peptides with generator-produced (68)Ga and using NaCl-based cationic elution methodDirk Mueller, Wouter A P Breeman, Ingo Klette, et al.
Nuclear Medicine and Biology|July 13, 2004
Reduction of skeletal accumulation of radioactivity by co-injection of DTPA in [90Y-DOTA0,Tyr3]octreotide solutions containing free 90Y3+Wouter A P Breeman, Maarten Th M De Jong, Erik De Blois, et al.
Pageof 3